Skip to main content
. 2003 Jan;77(2):989–998. doi: 10.1128/JVI.77.2.989-998.2003

TABLE 1.

Comparison of SHIVSF162 and SHIVSF162P3 infection in IVAG challenge of rhesus macaques

Virus No. infected/no. challenged Clinical outcome Reference
SHIVSF162 clone 0/3 None 50
SHIVSF162P3 isolate 7/9 Seroconversion, gradual depletion of CD4+ PBMC, SAIDS, severe mucosal CD4+-T-cell loss in 4 of 7 infected animals 26; unpublished data